ADT
46
6
FSLR
76
4
MOS
32
7
EL
52
10
LEG
29
2
WHR
59
4
DVN
21
-6
URBN
38
2
XRX
52
4
TGNA
48
3
NUE
57
3
WBA
19
3
LH
48
2
C
58
3
AN
52
2
ADI
61
2
NVDA
61
-2
FDX
33
2
ZTS
60
4
SJM
46
7
ADT
46
6
FSLR
76
4
MOS
32
7
EL
52
10
LEG
29
2
WHR
59
4
DVN
21
-6
URBN
38
2
XRX
52
4
TGNA
48
3
NUE
57
3
WBA
19
3
LH
48
2
C
58
3
AN
52
2
ADI
61
2
NVDA
61
-2
FDX
33
2
ZTS
60
4
SJM
46
7
Financhill
Back

NovoCure Vs. Triumph Financial Industry Stock Comparison

Sell
16

NVCR
NovoCure

Last Price:
15.64
Seasonality Move:
-4.91%
Sell
46

TFIN
Triumph Financial

Last Price:
78.51
Seasonality Move:
12.89%
Sell
16
NovoCure (NVCR) is a Sell

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $15.64. The Score for NVCR is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • NVCR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
46
Triumph Financial (TFIN) is a Sell

Is Triumph Financial a Buy, Sell or Hold?

  • The current Triumph Financial [TFIN] share price is $77.20. The Score for TFIN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • TFIN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $15.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVCR is experiencing selling pressure, which indicates risk of future bearish movement.

TFIN Stock Price Chart

What is Triumph Financial's stock price today?

  • The Triumph Financial share price today is $77.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TFIN is experiencing selling pressure, which indicates risk of future bearish movement.

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.54 Sell
Relative Strength Index (14 RSI): 36.62 Sell
Chaikin Money Flow: -380139 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.49 - 18.59) Sell
Bollinger Bands (100): (16.83 - 21.25) Sell

TFIN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.91 Sell
Relative Strength Index (14 RSI): 38 Sell
Chaikin Money Flow: -88106 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (79.12 - 83.7) Sell
Bollinger Bands (100): (74.95 - 85.81) Sell

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.94 Sell
20-day SMA: 17.38 Sell
50-day SMA: 18.39 Sell
200-day SMA: 16.63 Sell
8-day EMA: 16.64 Sell
20-day EMA: 17.26 Sell
50-day EMA: 17.9 Sell
200-day EMA: 20.01 Sell

TFIN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 80.91 Sell
20-day SMA: 80.79 Sell
50-day SMA: 83.23 Sell
200-day SMA: 77.84 Sell
8-day EMA: 79.9 Sell
20-day EMA: 80.94 Sell
50-day EMA: 81.64 Sell
200-day EMA: 77.3 Sell

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.66 per share, and a decrease next year of $0.12 per share.

Triumph Financial Earnings Growth & TFIN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, an increase next quarter of $0.37 per share, a decrease this year of $0.90 per share, and an increase next year of $1.31 per share.

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Triumph Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):